<DOC>
	<DOC>NCT02617706</DOC>
	<brief_summary>EPIFLO® unit along with standard wound care vs only standard wound care for Surgical site infections (SSI).</brief_summary>
	<brief_title>Transdermal Continuous Oxygen Therapy for Infection Prophylaxis in High- Risk Patients Undergoing Colon and Rectal Resections</brief_title>
	<detailed_description>Anorectal procedures more often lead to surgical site infections. Such infections are unfortunately frequent and can be difficult for the patient and the treating physician. Wound hypoxia has been identified as a pathogenic mechanism behind wound infection and poor healing. Transdermal oxygen delivery (EPIFLO) is intended to promote the healing process in chronic wounds as an adjunct to standard wound care in wound management and treatment</detailed_description>
	<mesh_term>Infection</mesh_term>
	<criteria>Elective colorectal surgery with or without anastomosis and with or without stoma Patient age: 1880 Pregnancy Anesthesiology ASA score of 4 or above fever or existing signs of infection at the time of surgery Diabetes Mellitus type I or II with HbA1C level 12% or more Persons with decubitus or diabetic ulcers Subjects with peritoneal metastases Patients with severe malnutrition as indicated by Prealbumin value of &lt;20 BMI ≥50</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Anorectal surgeries</keyword>
	<keyword>infection</keyword>
	<keyword>topical oxygen</keyword>
</DOC>